Aarti Drugs Limited (NSE:AARTIDRUGS)

Aarti Drugs Statistics

Total Valuation

Aarti Drugs has a market cap or net worth of INR 34.54 billion. The enterprise value is 40.22 billion.

Market Cap	34.54B
Enterprise Value	40.22B

Important Dates

The last earnings date was Friday, May 15, 2026.

Earnings Date	May 15, 2026
Ex-Dividend Date	Feb 9, 2026

Share Statistics

Current Share Class	91.27M
Shares Outstanding	n/a
Shares Change (YoY)	-0.02%
Shares Change (QoQ)	-0.05%
Owned by Insiders (%)	47.31%
Owned by Institutions (%)	19.19%
Float	35.37M

Valuation Ratios

The trailing PE ratio is 17.72 and the forward PE ratio is 16.87.

PE Ratio	17.72
Forward PE	16.87
PS Ratio	1.35
PB Ratio	2.23
P/TBV Ratio	2.25
P/FCF Ratio	43.06
P/OCF Ratio	13.62
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.91, with an EV/FCF ratio of 50.14.

EV / Earnings	20.64
EV / Sales	1.57
EV / EBITDA	12.91
EV / EBIT	16.44
EV / FCF	50.14

Financial Position

The company has a current ratio of 1.59, with a Debt / Equity ratio of 0.37.

Current Ratio	1.59
Quick Ratio	0.93
Debt / Equity	0.37
Debt / EBITDA	1.85
Debt / FCF	7.19
Interest Coverage	7.26

Financial Efficiency

Return on equity (ROE) is 13.36% and return on invested capital (ROIC) is 10.98%.

Return on Equity (ROE)	13.36%
Return on Assets (ROA)	5.67%
Return on Invested Capital (ROIC)	10.98%
Return on Capital Employed (ROCE)	12.92%
Weighted Average Cost of Capital (WACC)	6.12%
Revenue Per Employee	20.00M
Profits Per Employee	1.52M
Employee Count	1,284
Asset Turnover	0.95
Inventory Turnover	3.36

Taxes

In the past 12 months, Aarti Drugs has paid 159.70 million in taxes.

Income Tax	159.70M
Effective Tax Rate	7.57%

Stock Price Statistics

The stock price has decreased by -16.83% in the last 52 weeks. The beta is 0.36, so Aarti Drugs's price volatility has been lower than the market average.

Beta (5Y)	0.36
52-Week Price Change	-16.83%
50-Day Moving Average	360.94
200-Day Moving Average	425.17
Relative Strength Index (RSI)	53.49
Average Volume (20 Days)	167,006

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Aarti Drugs had revenue of INR 25.68 billion and earned 1.95 billion in profits. Earnings per share was 21.36.

Revenue	25.68B
Gross Profit	9.49B
Operating Income	2.45B
Pretax Income	2.11B
Net Income	1.95B
EBITDA	3.12B
EBIT	2.45B
Earnings Per Share (EPS)	21.36

Balance Sheet

The company has 242.80 million in cash and 5.77 billion in debt, with a net cash position of -5.52 billion.

Cash & Cash Equivalents	242.80M
Total Debt	5.77B
Net Cash	-5.52B
Net Cash Per Share	n/a
Equity (Book Value)	15.49B
Book Value Per Share	169.79
Working Capital	5.46B

Cash Flow

In the last 12 months, operating cash flow was 2.54 billion and capital expenditures -1.73 billion, giving a free cash flow of 802.20 million.

Operating Cash Flow	2.54B
Capital Expenditures	-1.73B
Depreciation & Amortization	669.70M
Net Borrowing	-269.80M
Free Cash Flow	802.20M
FCF Per Share	n/a

Margins

Gross margin is 36.96%, with operating and profit margins of 9.53% and 7.59%.

Gross Margin	36.96%
Operating Margin	9.53%
Pretax Margin	8.21%
Profit Margin	7.59%
EBITDA Margin	12.13%
EBIT Margin	9.53%
FCF Margin	3.12%

Dividends & Yields

This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 0.50%.

Dividend Per Share	2.00
Dividend Yield	0.50%
Dividend Growth (YoY)	100.00%
Years of Dividend Growth	n/a
Payout Ratio	9.32%
Buyback Yield	0.02%
Shareholder Yield	0.52%
Earnings Yield	5.64%
FCF Yield	2.32%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on September 30, 2020. It was a forward split with a ratio of 4.

Last Split Date	Sep 30, 2020
Split Type	Forward
Split Ratio	4

Scores

Altman Z-Score	n/a
Piotroski F-Score	6